Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...

A gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...

Union minister G Kishan Reddy has written to the health minister about concerns over online pharmacies. These platforms are accused of deep...

Pregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...

Bio Medica Laboratories' initial public offering begins subscription on Thursday. The company plans to raise Rs 52.43 crore through its IPO...

Erik Fleming, a drug counselor, received a two-year prison sentence. He supplied Matthew Perry with ketamine that led to the actor's death....

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Cannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

"We have asked the government to intervene and issue an order to stop advertising, displaying and offering discounts," said Sandeep Nangia,...

This is similar to the face-off between pharma companies and the All India Organisation of Chemists and Druggists (AIOCD), an organisation ...

The meeting would take place days ahead of reviews of vaccine candidates from Moderna Inc and Pfizer-BioNTech SE Inc by two separate panels...

CCI’s order asking drug distributors to desist from anti-competitive practices has triggered a war of words.

Domestic drugmakers alleged that distributors and retailers are planning to boycott three leading companies — Sun Pharma, Cadila Healthcare...

Pharmaceutical companies and distributors have decided to calculate “loss to trade channels” on account of the new pricing policy.

The government may allow pharma companies one more month from the cut-off date of July 29 to re-label their essential drug products.

Chemists usually get a 20% margin on drugs outside the price control net and 16% on those under price controls.